TC
FLGT icon

Truvestments Capital’s Fulgent Genetics FLGT Stock Holding History

Truvestments Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50
Closed -$924 – 1068
2024
Q4 		$924 Hold
50
– – ﹤0.01% 926
2024
Q3 		$1.09K Buy
+50
New +$1.12K ﹤0.01% 851
2024
Q1 		– Sell
-4
Closed -$116 – 778
2023
Q4 		$116 Hold
4
– – ﹤0.01% 778
2023
Q3 		$107 Hold
4
– – ﹤0.01% 672
2023
Q2 		$148 Hold
4
– – ﹤0.01% 680
2023
Q1 		$125 Buy
+4
New +$129 ﹤0.01% 658

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Truvestments Capital's FLGT Position: Q1 2025 in Review

Truvestments Capital sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 50 shares — an estimated $924 sold.

Truvestments Capital first reported a position in FLGT in Q1 2023 and held it in 6 quarters. The position peaked at $1.09K in Q3 2024. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

  • Truvestments Capital reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
  • Truvestments Capital sold 50 Fulgent Genetics shares in Q1 2025, an estimated $924.
  • Truvestments Capital first reported a position in Fulgent Genetics in Q1 2023 and held it in 6 quarters.
  • Truvestments Capital's Fulgent Genetics position peaked at $1.09K in Q3 2024.
  • 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on Truvestments Capital's 13F filing for Q1 2025, filed 14 May 2025.